How will you benefit from investing early in mutual funds?

Glenmark Life Sciences will finalise its IPO share allotment on Wednesday. Earlier, the public offer of the company got subscribed 44.17 times on the closing day of the subscription on July 29. The Rs 1,513.6-crore IPO received bids for 66,33,24,160 shares against 1,50,18,279 shares on offer, according to NSE data.

Qualified Institutional Buyers (QIBs) portion received 36.97 times subscription, non-institutional investors 122.54 times and retail individual investors 14.63 times. The company had fixed a price band of Rs 695-720 per share.

Glenmark Life Sciences, a subsidiary of Glenmark Pharmaceuticals, is a leading developer and manufacturer of select high-value, non-commoditised active pharmaceutical ingredients (APIs) in chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes.

The company also manufactures and sells APIs for gastro-intestinal disorders, anti-infectives, and other therapeutic areas.

Market participants are now looking forward to the share allotment status. Investors can check their allotment status by using any one of the below two methods:

Check IPO allotment on registrar’s website

Go to the website of the IPO registrar, KFintech or click on https://ris.kfintech.com/ipostatus/ipos.aspx

Thereafter you need to select Glenmark Life Sciences in the drop-down menu

Then enter either application number or DPID/ Client ID or Permanent Account Number and enter the captcha code and click on submit to view your share allotment status.

Check IPO allotment through the BSE website

Go to BSEIndia.com or click

Click on investors > Status of Issue Application > Application Status Check or (visit the link: https://www.bseindia.com/investors/appli_check.aspx)

Select issue type (equity) and Issue Name (Glenmark Life Sciences).

Enter the application number and PAN Number.

Click on the search button to know the IPO allotment status.